Log in

LON:TILS - Tiziana Life Sciences Share Price, Forecast & News

GBX 24.50
-3.00 (-10.91 %)
(As of 02/28/2020 04:00 PM ET)
Today's Range
26
Now: GBX 24.50
26
50-Day Range
24.50
MA: GBX 39.42
51.50
52-Week Range
26.10
Now: GBX 24.50
82.50
Volume4,752 shs
Average Volume4,999 shs
Market Capitalization£33.48 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. The company's product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as non-alcoholic steatohepatitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma. Read More…

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-74952379

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowGBX 0.27 per share
Book ValueGBX (2.40) per share

Profitability

Miscellaneous

Employees10
Market Cap£33.48 million
Next Earnings DateN/A
OptionableNot Optionable

Receive TILS News and Ratings via Email

Sign-up to receive the latest news and ratings for TILS and its competitors with MarketBeat's FREE daily newsletter.


Tiziana Life Sciences (LON:TILS) Frequently Asked Questions

What is Tiziana Life Sciences' stock symbol?

Tiziana Life Sciences trades on the London Stock Exchange (LON) under the ticker symbol "TILS."

How were Tiziana Life Sciences' earnings last quarter?

Tiziana Life Sciences PLC (LON:TILS) issued its earnings results on Thursday, June, 7th. The biotechnology company reported ($6.40) earnings per share (EPS) for the quarter, topping the consensus estimate of ($10.00) by $3.60. View Tiziana Life Sciences' Earnings History.

Has Tiziana Life Sciences been receiving favorable news coverage?

Media stories about TILS stock have been trending extremely negative recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Tiziana Life Sciences earned a media sentiment score of -4.6 on InfoTrie's scale. They also assigned media headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Tiziana Life Sciences.

Who are some of Tiziana Life Sciences' key competitors?

What other stocks do shareholders of Tiziana Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tiziana Life Sciences investors own include Synergy Pharmaceuticals (SGYP), Motif Bio (MTFB), Savannah Resources (SAV), Allstate (ALL), Envision Healthcare (EVHC), Avesoro Resources (ASO), Angus Energy (ANGS), Allergy Therapeutics (AGY), Active Energy Group (AEG) and Namibian Resources (AAOG).

Who are Tiziana Life Sciences' key executives?

Tiziana Life Sciences' management team includes the folowing people:
  • Mr. Gabriele Marco Antonio Cerrone M.B.A., MBA, Founder & Exec. Chairman (Age 47)
  • Dr. Kunwar Shailubhai, CEO, Chief Scientific Officer & Exec. Director (Age 61)
  • Dr. Andrea Brancale, Scientific Founder
  • Mr. Richard Clarkson Ph.D., Scientific Founder
  • Mr. Andrew Westwell Ph.D., Scientific Founder

How do I buy shares of Tiziana Life Sciences?

Shares of TILS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Tiziana Life Sciences' stock price today?

One share of TILS stock can currently be purchased for approximately GBX 24.50.

How big of a company is Tiziana Life Sciences?

Tiziana Life Sciences has a market capitalization of £33.48 million. Tiziana Life Sciences employs 10 workers across the globe.View Additional Information About Tiziana Life Sciences.

What is Tiziana Life Sciences' official website?

The official website for Tiziana Life Sciences is http://www.tizianalifesciences.com/.

How can I contact Tiziana Life Sciences?

Tiziana Life Sciences' mailing address is 3rd Fl, 11-12 St. James's Square, LONDON, SW1Y 4LB, United Kingdom. The biotechnology company can be reached via phone at +44-20-74952379.


MarketBeat Community Rating for Tiziana Life Sciences (LON TILS)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  116 (Vote Outperform)
Underperform Votes:  197 (Vote Underperform)
Total Votes:  313
MarketBeat's community ratings are surveys of what our community members think about Tiziana Life Sciences and other stocks. Vote "Outperform" if you believe TILS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TILS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/29/2020 by MarketBeat.com Staff

Featured Article: Recession

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel